Abstract: The present invention is directed to a pharmaceutical and/or dietary supplement composition comprising an effective amount of a copper (I) complex with glycine, pyruvate, or succinic acid and methods of treating mitochondrial, neuromuscular, and other diseases. Also provided are pharmaceutical treatment regimes and kits comprising a copper (I) complex with glycine, pyruvate, or succinate.
Type:
Grant
Filed:
September 15, 2017
Date of Patent:
March 24, 2020
Assignee:
C Lab Pharma International, S.A.
Inventors:
Charles Louis Albartus Barker, William A. Boulanger
Abstract: The present invention relates to metal complexes and methods of synthesizing the metal complexes. The invention is further directed to pharmaceutical and/or dietary supplement composition comprising compounds synthesized as described herein.
Type:
Grant
Filed:
September 8, 2015
Date of Patent:
April 16, 2019
Assignee:
C Lab Pharma International, S.A.
Inventors:
Charles Louis Albartus Barker, Siead Zegar, Kurt Wachholder
Abstract: A method of manufacturing an anhydrous copper complex of formula C12H10ClCuN2O4 and methods of treating neuromuscular and other diseases, including but not limited to fibromyalgia, multiple sclerosis, muscular dystrophy, rheumatoid arthritis, pain, fatigue, sleeplessness, loss of fine motor control, speech loss, inflexibility, Alzheimer's, dementia, amyotrophic lateral sclerosis, depression, lyme disease, lyme disease co-infection, gastroparesis (GP), myopathy, chronic inflammation and/or incontinence. The anhydrous copper complex preferably is administered in a pharmaceutical and/or dietary supplement composition of the invention.
Type:
Grant
Filed:
April 21, 2015
Date of Patent:
May 17, 2016
Assignee:
C LAB PHARMA INTERNATIONAL, S.A.
Inventors:
Sean Kerrigan, Nolan Mente, Charles Louis Albartus Barker
Abstract: A method of manufacturing an anhydrous copper complex of formula C12H10CICuN2O4 and methods of treating neuromuscular and other diseases, including but not limited to fibromyalgia, multiple sclerosis, muscular dystrophy, rheumatoid arthritis, pain, fatigue, sleeplessness, loss of fine motor control, speech loss, inflexibility, Alzheimer's, dementia, amyotrophic lateral sclerosis, depression, lyme disease, lyme disease co-infection, gastroparesis (GP), myopathy, chronic inflammation and/or incontinence. The anhydrous copper complex preferably is administered in a pharmaceutical and/or dietary supplement composition of the invention.
Type:
Grant
Filed:
August 9, 2012
Date of Patent:
May 26, 2015
Assignee:
C LAB PHARMA INTERNATIONAL, S.A.
Inventors:
Sean Kerrigan, Nolan Mente, Charles Louis Albartus Barker
Abstract: A method of manufacturing an anhydrous copper complex of formula C12H10CICuN2O4 and methods of treating neur-muscular and other diseases, including but not limited to fibromyalgia, multiple sclerosis, muscular dystrophy, rheumatoid arthritis, pain, fatigue, sleeplessness, loss of fine motor control, speech loss, inflexibility, Alzheimer's, dementia, amyotrophic lateral sclerosis, depression, lyme disease, lyme disease co-infection, gastroparesis (GP), myopathy, chronic inflammation and/or incontinence. The anhydrous copper complex preferably is administered in a pharmaceutical and/or dietary supplement composition of the invention.
Type:
Application
Filed:
August 9, 2012
Publication date:
August 28, 2014
Applicant:
C Lab Pharma International S.A.
Inventors:
Sean Kerrigan, Nolan Mente, Charles Louis Albartus Barker